Content area
Full Text
Medsafe, the New Zealand Medicines and Medical Devices Safety Authority, is warning of a potential interaction between fluoxetine and levothyroxine products which may result in reduced serum levothyroxine concentrations and increased thyroid-stimulating hormone (TSH) levels, indicating reduced thyroid function.
A report to the Centre for Adverse...